Neuropsychiatry

The Neuropsychiatry Group is a collaborative group composed of staff from CHeBA and the Neuropsychiatric Institute (NPI) at the Prince of Wales Hospital, Sydney. The NPI is a tertiary referral unit that specialises in the diagnosis and treatment of cognitive and psychiatric disorders associated with medical and neurological illnesses. It is unique in Australia in bringing together expertise within Psychiatry, Neurology, Neuropsychology, Neurophysiology and Neurosurgery to bear upon complex diagnostic issues. The Neuropsychiatry Group is at the forefront of diagnostic research into neuropsychiatric disorders, in particular dementia, drug-induced movement disorders, Tourette syndrome and mental illness associated with epilepsy, and the use of brain stimulation (DBS, TMS, tDCS) for treatment. The group also provides important education services for clinicians and trainees.

Group Leader: Professor Perminder Sachdev Staff: Dr Adith Mohan, Dr Rebecca Koncz, Dr Matt Paradise

Professor Perminder Sachdev, Dr Rebecca Koncz, Dr Adith Mohan, Dr Matt Paradise

Professor Henry Brodaty (5th from right) at the ceremony 2018 Honours student Adrian Cheng

was awarded a scholarship by The Royal Australian and New Zealand College of Psychiatrists to present at their Congress based on his research supervised by CHeBA Co-Director Professor Henry Brodaty and drawing evidence from CHeBA's Sydney Centenarian Study.

Australian Mental Health Prize

CHeBA Co-Directors Professor Henry Brodaty and Professor Perminder Sachdev, both members of the Australian Mental Health Prize Committee, extend congratulations to the 2020 winners of this prestigious prize - Professor Gordon Parker and Professor Helen Milroy.